OriGene's lentiviral vectors (shRNA and overexpression lentiviral vectors) are 3 rd generation lentiviral vectors with improved biosafety. These safety features are discussed below.
• The number of genes from HIV-1 that are used in the 3 rd generation lenti system has been reduced to three (i.e. gag, pol, and rev) . TAT, an essential gene for viral replication is eliminated.
• A constitutive promoter (CMV promoter) has been placed upstream of the 5′ LTR in the pLenti expression vector to offset the requirement for Tat in the efficient production of viral RNA.
• The packing plasmids (Gag, pol, rev and VSV-G) supporting lentiviral packaging are separated onto three plasmids; none of them contain LTRs or the Ψ packaging sequence.
Only the lenti vector for gene overexpression or shRNA knockdown contains the packaging signal that can be packaged into viral particles.
• The VSV-G gene from Vesicular Stomatitis Virus is used as the pseudo-envelope, further reducing the chances of recombination with viral genome.
Despite the safety features discussed, the lenti viruses produced with OriGene's lenti system can still pose some biohazardous risk since it can transduce primary human cells. We highly recommend that you treat lentiviral stocks generated using this system as Biosafety Level 2 (BL-2) organisms and strictly follow all published BL-2 guidelines with proper waste decontamination. Furthermore, exercise extra caution when creating lentivirus carrying potential harmful or toxic genes (e.g. activated oncogenes).
For more information about the BL-2 guidelines and lentivirus handling, Please find more details at http://oba.od.nih.gov/rdna_rac/rac_guidance_lentivirus.html
